Vancouver, British Columbia – Further to its news release of November 17, 2021, HEMP FOR HEALTH INC. (CSE: HFH) (FSE: 9HH) (the “Company”) announces revisions to its previously announced private placement. The Company has increased the size of the financing and will be raising up to $1.2 million through the issuance of up to 24,000,000 units (“Unit”) at a price of $0.05 per Unit. Each Unit will consist of one post-consolidated share and one-half of one common share purchase warrant (“Warrant”), with each whole Warrant entitling the holder to purchase one post-consolidated share at $0.10 per share for a period of 24 months from closing. The term of the Warrants may be reduced should the Company’s shares trade at or above $0.20 for 30 consecutive days on a Canadian stock exchange.
Proceeds from the Financing will be used to investigate new business opportunities, and for general working capital. The Company may pay finders’ fees with respect to this Financing.
Securities issued in connection with the financing will be subject to a hold period of four months and one day. The Company will be filing an Amended Form 9 on the CSE’s website.
ON BEHALF OF HEMP FOR HEALTH INC.
“(sgd.)” Robert Eadie
President & CEO
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
FOR FURTHER INFORMATION PLEASE CONTACT: Robert Eadie
Toll Free: 1-866-602-4935